Found: 5
Select item for more details and to access through your institution.
Integrating the 40-Gene Expression Profile (40-GEP) Test Improves Metastatic Risk-Stratification Within Clinically Relevant Subgroups of High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 3, p. 593, doi. 10.1007/s13555-024-01111-5
- By:
- Publication type:
- Article
Current Methods and Caveats to Risk Factor Assessment in Cutaneous Squamous Cell Carcinoma (cSCC): A Narrative Review.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 2, p. 267, doi. 10.1007/s13555-021-00673-y
- By:
- Publication type:
- Article
Clinical Utility of the 40-Gene Expression Profile (40-GEP) Test for Improved Patient Management Decisions and Disease-Related Outcomes when Combined with Current Clinicopathological Risk Factors for Cutaneous Squamous Cell Carcinoma (cSCC): Case Series.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 2, p. 591, doi. 10.1007/s13555-021-00665-y
- By:
- Publication type:
- Article
The p53-Reactivating Small Molecule RITA Induces Senescence in Head and Neck Cancer Cells.
- Published in:
- PLoS ONE, 2014, v. 9, n. 8, p. 1, doi. 10.1371/journal.pone.0104821
- By:
- Publication type:
- Article
Analytical validity of DecisionDx-SCC, a gene expression profile test to identify risk of metastasis in cutaneous squamous cell carcinoma (SCC) patients.
- Published in:
- Diagnostic Pathology, 2022, v. 17, n. 1, p. 1, doi. 10.1186/s13000-022-01211-w
- By:
- Publication type:
- Article